These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 3922267)
41. [Pulmonary function and pulmonary hemodynamics in obstructive sleep apnea syndrome]. Kurashina K; Akashiba T; Horie T Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Nov; 30(11):1923-30. PubMed ID: 1484430 [TBL] [Abstract][Full Text] [Related]
42. The effects of controlled oxygen therapy on ventricular function in patients with stable and decompensated cor pulmonale. MacNee W; Wathen CG; Flenley DC; Muir AD Am Rev Respir Dis; 1988 Jun; 137(6):1289-95. PubMed ID: 3202369 [TBL] [Abstract][Full Text] [Related]
43. Pulmonary hemodynamics in patients with chronic obstructive pulmonary disease before and during an episode of peripheral edema. Weitzenblum E; Apprill M; Oswald M; Chaouat A; Imbs JL Chest; 1994 May; 105(5):1377-82. PubMed ID: 8181323 [TBL] [Abstract][Full Text] [Related]
44. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Zieliński J; Tobiasz M; Hawryłkiewicz I; Sliwiński P; Pałasiewicz G Chest; 1998 Jan; 113(1):65-70. PubMed ID: 9440570 [TBL] [Abstract][Full Text] [Related]
45. [Effects of nifedipine on pulmonary hypertension in patients with chronic obstructive pulmonary diseases--a comparison with oxygen administration]. Liu Z; Yu RJ Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):146-8, 189. PubMed ID: 1913960 [TBL] [Abstract][Full Text] [Related]
46. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Agostoni P; Doria E; Galli C; Tamborini G; Guazzi MD Am Rev Respir Dis; 1989 Jan; 139(1):120-5. PubMed ID: 2912331 [TBL] [Abstract][Full Text] [Related]
47. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Keller CA; Shepard JW; Chun DS; Dolan GF; Vasquez P; Minh VD Am Rev Respir Dis; 1984 Oct; 130(4):606-11. PubMed ID: 6486560 [TBL] [Abstract][Full Text] [Related]
48. Selection of patients for long-term oxygen therapy (LTO). Levi-Valensi P; Aubry P; Rida Z; Rose D; Ndarurinze S; Jounieaux V Eur Respir J Suppl; 1989 Jul; 7():624s-629s. PubMed ID: 2508650 [TBL] [Abstract][Full Text] [Related]
49. Frequency and mechanism of daytime pulmonary hypertension in patients with obstructive sleep apnoea syndrome. Apprill M; Weitzenblum E; Krieger J; Oswald M; Kurtz D Cor Vasa; 1991; 33(1):42-9. PubMed ID: 1914466 [TBL] [Abstract][Full Text] [Related]
50. Predictors of survival in patients treated with long-term oxygen therapy. MacNee W Respiration; 1992; 59 Suppl 2():5-7. PubMed ID: 1513973 [TBL] [Abstract][Full Text] [Related]
51. Hypoxic pulmonary hypertension: haemodynamic changes after oxygen and various vasodilators in the same patient at different time periods. Král H; Hamet A; Cernohorský D; Stásek J; Tilser P Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(4-5):317-24. PubMed ID: 8599074 [TBL] [Abstract][Full Text] [Related]
52. Pulmonary haemodynamics in patients with OSAS or an overlap syndrome. Hawryłkiewicz I; Sliwiński P; Górecka D; Pływaczewski R; Zieliński J Monaldi Arch Chest Dis; 2004; 61(3):148-52. PubMed ID: 15679007 [TBL] [Abstract][Full Text] [Related]
53. Measurement of right ventricular ejection fraction with krypton-81m in chronic obstructive pulmonary disease. Wolf JE; Fagret D; Godart J; Comet M; Paramelle B Bull Eur Physiopathol Respir; 1986; 22(6):539-44. PubMed ID: 3828544 [TBL] [Abstract][Full Text] [Related]
54. Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease. Oelberg DA; Kacmarek RM; Pappagianopoulos PP; Ginns LC; Systrom DM Am J Respir Crit Care Med; 1998 Dec; 158(6):1876-82. PubMed ID: 9847281 [TBL] [Abstract][Full Text] [Related]
55. Effects of removing oxygen from patients with chronic obstructive pulmonary disease. Selinger SR; Kennedy TP; Buescher P; Terry P; Parham W; Gofreed D; Medinger A; Spagnolo SV; Michael JR Am Rev Respir Dis; 1987 Jul; 136(1):85-91. PubMed ID: 3605848 [TBL] [Abstract][Full Text] [Related]
56. Treatment of acute exacerbations with non-invasive ventilation in chronic hypercapnic COPD patients with pulmonary hypertension. Parola D; Romani S; Petroianni A; Locorriere L; Terzano C Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):183-91. PubMed ID: 22428469 [TBL] [Abstract][Full Text] [Related]
57. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study. Tuxen DV; Powles AC; Mathur PN; Pugsley SO; Campbell EJ Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627 [TBL] [Abstract][Full Text] [Related]
58. Improvement of right ventricular systolic performance by long-term domiciliary oxygen therapy in patients with chronic respiratory failure. Ikuma I; Ishibashi Y; Murakami Y; Nakazawa Y; Murakami R; Morioka S; Moriyama K Jpn Circ J; 1989 Jul; 53(7):756-65. PubMed ID: 2810687 [TBL] [Abstract][Full Text] [Related]
59. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Dal Nogare AR; Rubin LJ Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247 [TBL] [Abstract][Full Text] [Related]